Eight major RCTs of GLP-1RAs have investigated the cardiovascular outcomes, including the ELIXA trial of lixisenatide (250), the EXSCEL trial of exenatide ER (251), the LEARDER trial of liraglutide (252), the SUSTAIN-6 trial of subcutaneous semaglutide (253), the HARMONY trial of albiglutide (228), the REWIND trial of dulaglutide (254), the PIONEER trial of oral semaglutide (255), and the SELECT trial of subcutaneous semaglutide (199)
Related Reading Injection Semaglutide Wegovy Out Of Pocket Cost Ozempic Out Of Pocket Cost Semaglutide Cost With Insurance Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
However, if you have any concerns or your symptoms persist, don't hesitate to talk to your doctor
GLP-1 is a drug to promote weight loss in people who are considered obese and/or overweight